On Friday, Neurocrine Biosciences Inc (NBIX) stock saw a modest uptick, ending the day at $143.26 which represents a slight increase of $1.34 or 0.94% from the prior close of $141.92. The stock opened ...

On Thursday, Oppenheimer reiterated its Outperform rating on shares of Neurocrine (NASDAQ:NBIX) Biosciences (NASDAQ:NBIX), currently trading at $141.24, with a steady price target of $192.00. The firm ...

On Thursday, Oppenheimer reiterated its Outperform rating on shares of Neurocrine (NASDAQ:NBIX) Biosciences (NASDAQ:NBIX), currently trading at $141.24, with a steady price target of $192.00.

Harrison Smith fought back tears in the aftermath of the Minnesota Vikings‘ season-ending loss to the Los Angeles Rams. His 200th career game, all with the Vikings, brought a magical season to a ...

Kansas City Chief Travis Kelce joined Stephen A. Smith on Wednesday night on the Stephen A. Smith Show, and the conversation naturally turned to the tight end’s high-profile personal life.

Martin Dubravka, Miguel Almiron and more recently, Lloyd Kelly have been linked with moves away from St. James' Park, but none of those deals are as clear cut as Newcastle would like. Here ...

Neurocrine Bioscience Inc. said in a federal lawsuit that Spruce Biosciences Inc. is threatening patent litigation over its new rare disease drug Crenessity due to a “desperate need for cash”.

$50,000 of NEUROCRINE BIOSCIENCES INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues regarding potential ...

Defense Secretary Lloyd Austin’s hospitalization scandal last year increased national security risks and should have been handled better, according to a new report from the Pentagon’s watchdog.

The Pentagon inspector general found in its review of Secretary of Defense Lloyd Austin's hospitalization last year that it "increased unnecessarily" the risks to national security, even if ...

The secrecy surrounding Secretary of Defense Lloyd Austin’s hospitalizations in late 2023 and early 2024 “increased unnecessarily” the risks to US national security, the Pentagon’s ...